7th Guide to German Medtech Companies 2022

Angebote / Angebote:

With the coronavirus pandemic still ongoing, the medical technology sector is faced with challenges that never have been larger. On the one hand, companies are dealing with the complex requirements of the EU MDR regulations and try to keep their medical product potfolio in the European market. On the other hand, they are con- fronted with extreme fluctuations in the demand site, which makes sales expectations more difficult to plan. However, and that's the good news, German medtech compa- nies still constitutes a well-established pillar within the healthcare industry in Ger- many and could provide a major part to the country's export-driven economic growth, even during these challenging times. For 2021, economic experts estimate that around 36 billion euros of revenue will be generated, a 8% plus compared to 2020 - which brings the sector back on the growth track of the previous years. The robust condition of the sector owes to the very German-like combination of tradition and inventiveness, resulting in a good hands-on mentality in dealing with an unprecedent crisis. An- other of the sector's competences which helped to provide stable business activities is its ability to cross-link with the pharma, IT, and manufacturing sectors. With the seventh edition of our "Guide to German Medtech Companies", BIOCOM AG follows this development, highlighting the broad competences of the German medical technology sector. The Guide offers a diverse compendium of companies - from medical device developers to manufacturers, service providers, medtech event organisers and organisations. In addition, most recent trends in the sector are summarised in the introduction, for instance digital health and automation. The Guide to German Medtech Companies is supported by our partners Germany Trade & Invest, BVMed e.V., Medical Valley EMN e.V., Life Science Nord, Medical Mountains, SPECTARIS, Forum MedTech Pharma, MicroTec Südwest, IVAM, and VDMA. These national organisations and regional networks are important stakehold- ers, helping to establish further growth of "Medtech made in Germany" by providing the right environment for traditional family-owned firms, global players, start-ups, technological forerunners, manufacturers, suppliers, and service providers. As this book will be distributed digitally and with the support of many interna- tional medtech stakeholders in Europe and overseas, it will definitely provide strong visibility of German medical technology companies on an international level. The publication is also available for free via our BIOCOM AG website. Electronic version or as printed copy: the Guide is bound to become a must-have on the desk of health professionals in Germany and beyond.